These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 18378338)
1. Beta-adrenergic blockers in chronic systolic heart failure secondary to Chagas' disease. Dávila DF; Donis JH; Torres A; Gottberg CF; Ramoni-Perazzi P; Arata de Bellabarba G Int J Cardiol; 2008 Aug; 128(1):1-4. PubMed ID: 18378338 [No Abstract] [Full Text] [Related]
2. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy. Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318 [TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy. Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas' cardiomyopathy. Miguel CE; Bortoluzzi TB; Otaviano AP; Cardinalli-Neto A; Rocha BF; Ferrari SJ; Bestetti RB Acta Trop; 2011 Dec; 120(3):219-23. PubMed ID: 21906579 [TBL] [Abstract][Full Text] [Related]
10. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155 [TBL] [Abstract][Full Text] [Related]
11. A summary perspective on the clinical-functional significance of cardiac autonomic dysfunction in Chagas' disease. Junqueira LF Rev Soc Bras Med Trop; 2006; 39 Suppl 3():64-9. PubMed ID: 17605211 [No Abstract] [Full Text] [Related]
13. Cardiac autonomic modulation evaluated by heart interval variability is unaltered but subtly widespread in the indeterminate Chagas' disease. Correia D; Junqueira LF; Molina RJ; Prata A Pacing Clin Electrophysiol; 2007 Jun; 30(6):772-80. PubMed ID: 17547611 [TBL] [Abstract][Full Text] [Related]
14. Chagas' heart disease as an experimental model for studies of cardiac autonomic function in man. Amorim DS; Manço JC; Gallo L; Marin Neto JA Mayo Clin Proc; 1982 Jul; 57 Suppl():48-60. PubMed ID: 6811806 [TBL] [Abstract][Full Text] [Related]
15. Beta blockers in systolic heart failure. Lindsay DA Aust Fam Physician; 2008 Jun; 37(6):391; author reply 391. PubMed ID: 18597983 [No Abstract] [Full Text] [Related]
17. Assessment of QTc interval dispersion in patients with chronic heart failure secondary to Chagas-Hypertensive cardiomyopathy. Pinheiro MB; Bestetti RB; Cordeiro JA Int J Cardiol; 2007 Sep; 121(1):93-4. PubMed ID: 17126936 [TBL] [Abstract][Full Text] [Related]
18. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline. Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915 [TBL] [Abstract][Full Text] [Related]
19. [Chagas cardiomyopathy and the autonomic nervous system. Clinical studies]. Dávila Spinetti DF; Inglessis G; Mazzei de Dávila CA Arch Inst Cardiol Mex; 1999; 69(1):35-9. PubMed ID: 10367091 [TBL] [Abstract][Full Text] [Related]
20. Chagas' heart disease and the autonomic nervous system. Dávila DF; Inglessis G; Mazzei de Dávila CA Int J Cardiol; 1998 Sep; 66(2):123-7. PubMed ID: 9829322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]